Despite radiation exposure and fracture risk, pricey QCT bone density scans are rising in popularity

MedPage Today reported April 13 that quantitative computed tomography (QCT) bone density scans for osteoporosis screening are on the rise, in spite of their high costs and potentially questionable accuracy. 

Dual-energy X-ray absorptiometry (DXA) has long been the gold standard for osteoporosis screening. But now, thousands of patients may be inappropriately undergoing bone mineral density studies via quantitative computed tomography — which may be less accurate and more expensive, with far higher radiation exposure,” author Cheryl Clark writes. 

In examining possible reasons behind the rise in QCT orders — of which nearly half come from just four states — the article notes that reimbursement rates for DXA were cut drastically in 2007 under the Deficit Reduction Act, and that some clinicians have decommissioned their DXA scanners since then. 

Jessica Kania is a digital editor who has worked across the Innovate Healthcare brands, including Radiology Business, Health Imaging, AI in Healthcare and Cardiovascular Business. She also has vast experience working on custom content projects focused on technology innovation, clinical excellence, operational efficiency and improving financial performance in healthcare.  

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.